HB21-1307 Summary

• Caps total out-of-pocket costs for covered individuals at $100 per 30-day insulin supply regardless of insulin type or number of prescriptions starting January 1, 2022.

• Creates an insulin affordability program requiring manufacturers with over $2 million annual insulin revenue in Colorado to provide low-cost insulin to eligible Colorado residents by January 1, 2022.

• Establishes an emergency insulin supply program allowing eligible individuals to receive one 30-day supply within a 12-month period for $35 maximum copay when out-of-pocket costs exceed $100 monthly.

• Requires insulin manufacturers to reimburse pharmacies within 30 days for the difference between wholesale acquisition cost and patient payments, or provide replacement insulin supplies at no cost to pharmacies.

• Subjects non-compliant manufacturers to $10,000 monthly fines and clarifies that manufacturer reimbursements do not constitute illegal kickbacks under federal law.